nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—DCK—Gemcitabine—breast cancer	0.26	1	CbGbCtD
Emtricitabine—Lamivudine—Gemcitabine—breast cancer	0.232	0.446	CrCrCtD
Emtricitabine—Zalcitabine—Gemcitabine—breast cancer	0.2	0.386	CrCrCtD
Emtricitabine—Decitabine—Gemcitabine—breast cancer	0.0871	0.168	CrCrCtD
Emtricitabine—DCK—Pyrimidine salvage reactions—CDA—breast cancer	0.00692	0.162	CbGpPWpGaD
Emtricitabine—DCK—Purine salvage—APRT—breast cancer	0.00479	0.113	CbGpPWpGaD
Emtricitabine—DCK—Pyrimidine metabolism—CDA—breast cancer	0.00316	0.0741	CbGpPWpGaD
Emtricitabine—DCK—Pyrimidine metabolism—UMPS—breast cancer	0.00239	0.0562	CbGpPWpGaD
Emtricitabine—DCK—Purine metabolism—APRT—breast cancer	0.00228	0.0534	CbGpPWpGaD
Emtricitabine—DCK—Purine metabolism—ADSL—breast cancer	0.00185	0.0436	CbGpPWpGaD
Emtricitabine—DCK—nipple—breast cancer	0.00184	0.149	CbGeAlD
Emtricitabine—DCK—Pyrimidine metabolism—DPYD—breast cancer	0.00166	0.0389	CbGpPWpGaD
Emtricitabine—DCK—embryo—breast cancer	0.00152	0.123	CbGeAlD
Emtricitabine—Decitabine—DNMT3A—breast cancer	0.00143	0.295	CrCbGaD
Emtricitabine—DCK—Nucleotide metabolism—CDA—breast cancer	0.00123	0.0289	CbGpPWpGaD
Emtricitabine—DCK—Nucleotide metabolism—APRT—breast cancer	0.00114	0.0268	CbGpPWpGaD
Emtricitabine—Lamivudine—NME1—breast cancer	0.00111	0.23	CrCbGaD
Emtricitabine—DCK—endometrium—breast cancer	0.00111	0.09	CbGeAlD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—BARD1—breast cancer	0.00105	0.0246	CbGpPWpGaD
Emtricitabine—DCK—uterus—breast cancer	0.00102	0.083	CbGeAlD
Emtricitabine—DCK—pituitary gland—breast cancer	0.001	0.0815	CbGeAlD
Emtricitabine—DCK—adipose tissue—breast cancer	0.001	0.0811	CbGeAlD
Emtricitabine—DCK—Topotecan—Irinotecan—breast cancer	0.000961	0.281	CbGdCrCtD
Emtricitabine—DCK—Pyrimidine metabolism—TYMS—breast cancer	0.000945	0.0222	CbGpPWpGaD
Emtricitabine—DCK—Nucleotide metabolism—NME1—breast cancer	0.000932	0.0219	CbGpPWpGaD
Emtricitabine—DCK—Nucleotide metabolism—UMPS—breast cancer	0.000932	0.0219	CbGpPWpGaD
Emtricitabine—DCK—Nucleotide metabolism—ADSL—breast cancer	0.000932	0.0219	CbGpPWpGaD
Emtricitabine—DCK—female reproductive system—breast cancer	0.000919	0.0746	CbGeAlD
Emtricitabine—DCK—adrenal gland—breast cancer	0.000897	0.0728	CbGeAlD
Emtricitabine—DCK—bone marrow—breast cancer	0.000867	0.0704	CbGeAlD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—STMN1—breast cancer	0.000838	0.0197	CbGpPWpGaD
Emtricitabine—DCK—female gonad—breast cancer	0.000836	0.0679	CbGeAlD
Emtricitabine—DCK—endocrine gland—breast cancer	0.000778	0.0631	CbGeAlD
Emtricitabine—Decitabine—DNMT1—breast cancer	0.000772	0.16	CrCbGaD
Emtricitabine—DCK—Purine metabolism—GPX1—breast cancer	0.000694	0.0163	CbGpPWpGaD
Emtricitabine—DCK—Nucleotide metabolism—DPYD—breast cancer	0.000646	0.0152	CbGpPWpGaD
Emtricitabine—Floxuridine—TYMS—breast cancer	0.00063	0.13	CrCbGaD
Emtricitabine—DCK—lymph node—breast cancer	0.000537	0.0436	CbGeAlD
Emtricitabine—DCK—Epirubicin—Idarubicin—breast cancer	0.000492	0.144	CbGdCrCtD
Emtricitabine—DCK—Doxorubicin—Idarubicin—breast cancer	0.000492	0.144	CbGdCrCtD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—TOP2A—breast cancer	0.000491	0.0115	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—DNMT1—breast cancer	0.000481	0.0113	CbGpPWpGaD
Emtricitabine—DCK—Clomifene—Toremifene—breast cancer	0.000471	0.138	CbGdCrCtD
Emtricitabine—Lamivudine—ABCC1—breast cancer	0.000374	0.0773	CrCbGaD
Emtricitabine—DCK—Nucleotide metabolism—TYMS—breast cancer	0.000368	0.00864	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—ABL1—breast cancer	0.000355	0.00833	CbGpPWpGaD
Emtricitabine—DCK—Nucleotide metabolism—GPX1—breast cancer	0.000348	0.00818	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—CCNE1—breast cancer	0.000344	0.00806	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—breast cancer	0.000337	0.00792	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—E2F1—breast cancer	0.000323	0.00758	CbGpPWpGaD
Emtricitabine—DCK—Clomifene—Tamoxifen—breast cancer	0.000296	0.0864	CbGdCrCtD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—CDK2—breast cancer	0.000278	0.00653	CbGpPWpGaD
Emtricitabine—DCK—Desoximetasone—Fluoxymesterone—breast cancer	0.000277	0.0809	CbGdCrCtD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—CDK4—breast cancer	0.000263	0.00618	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—RB1—breast cancer	0.000229	0.00537	CbGpPWpGaD
Emtricitabine—DCK—Doxorubicin—Epirubicin—breast cancer	0.000226	0.066	CbGdCrCtD
Emtricitabine—DCK—Epirubicin—Doxorubicin—breast cancer	0.000209	0.061	CbGdCrCtD
Emtricitabine—Lamivudine—ABCG2—breast cancer	0.000197	0.0408	CrCbGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—MDM2—breast cancer	0.000195	0.00458	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—RAF1—breast cancer	0.000194	0.00456	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—breast cancer	0.000178	0.00418	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—breast cancer	0.00017	0.00399	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—breast cancer	0.000164	0.00386	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—SYNJ2—breast cancer	0.000147	0.00346	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—NDUFS3—breast cancer	0.000137	0.00322	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—MYC—breast cancer	0.000136	0.0032	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CHST9—breast cancer	0.000129	0.00303	CbGpPWpGaD
Emtricitabine—Zalcitabine—CYP2D6—breast cancer	0.000128	0.0265	CrCbGaD
Emtricitabine—DCK—Metabolism—COX11—breast cancer	0.000122	0.00287	CbGpPWpGaD
Emtricitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—breast cancer	0.000112	0.00263	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CDA—breast cancer	0.000112	0.00262	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—SHMT1—breast cancer	0.000112	0.00262	CbGpPWpGaD
Emtricitabine—Zalcitabine—CYP3A4—breast cancer	0.00011	0.0228	CrCbGaD
Emtricitabine—DCK—Metabolism—SLCO1B1—breast cancer	0.000108	0.00253	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—SLC2A5—breast cancer	0.000108	0.00253	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—APRT—breast cancer	0.000104	0.00244	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ESRRA—breast cancer	9.77e-05	0.00229	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ANGPTL4—breast cancer	9.77e-05	0.00229	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GPI—breast cancer	9.26e-05	0.00217	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—HADHB—breast cancer	9.26e-05	0.00217	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ALDH7A1—breast cancer	8.83e-05	0.00207	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ALDH1A1—breast cancer	8.83e-05	0.00207	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ADSL—breast cancer	8.47e-05	0.00199	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PHGDH—breast cancer	8.47e-05	0.00199	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—UMPS—breast cancer	8.47e-05	0.00199	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—NME1—breast cancer	8.47e-05	0.00199	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—FHL2—breast cancer	8.47e-05	0.00199	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—BRIP1—breast cancer	8.3e-05	0.00195	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—LDHB—breast cancer	8.3e-05	0.00195	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—HPSE—breast cancer	8.3e-05	0.00195	CbGpPWpGaD
Emtricitabine—Lamivudine—ABCB1—breast cancer	8.21e-05	0.017	CrCbGaD
Emtricitabine—DCK—Metabolism—GSTA3—breast cancer	7.87e-05	0.00185	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—HMMR—breast cancer	7.87e-05	0.00185	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ABCC1—breast cancer	7.87e-05	0.00185	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PPARGC1B—breast cancer	7.62e-05	0.00179	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GSTA4—breast cancer	7.2e-05	0.00169	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CA9—breast cancer	7.2e-05	0.00169	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GSTA2—breast cancer	7.02e-05	0.00165	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GPX2—breast cancer	7.02e-05	0.00165	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GPX4—breast cancer	6.93e-05	0.00163	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—SULT1A1—breast cancer	6.93e-05	0.00163	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—IDH1—breast cancer	6.77e-05	0.00159	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GSTA1—breast cancer	6.77e-05	0.00159	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—NAT2—breast cancer	6.69e-05	0.00157	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—MED12—breast cancer	5.87e-05	0.00138	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—DPYD—breast cancer	5.87e-05	0.00138	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ALDOA—breast cancer	5.78e-05	0.00136	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—NCOA3—breast cancer	5.61e-05	0.00132	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—SLC2A2—breast cancer	5.57e-05	0.00131	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—MTR—breast cancer	5.46e-05	0.00128	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ABCG2—breast cancer	5.46e-05	0.00128	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CPT1A—breast cancer	5.46e-05	0.00128	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—HPGDS—breast cancer	5.35e-05	0.00126	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—HBA1—breast cancer	5.32e-05	0.00125	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GSTT1—breast cancer	5.19e-05	0.00122	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ACHE—breast cancer	5.19e-05	0.00122	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CYP17A1—breast cancer	4.91e-05	0.00115	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ENO1—breast cancer	4.86e-05	0.00114	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PTGS1—breast cancer	4.86e-05	0.00114	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CYP2D6—breast cancer	4.77e-05	0.00112	CbGpPWpGaD
Emtricitabine—Asthenia—Mitoxantrone—breast cancer	4.72e-05	0.000299	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Epirubicin—breast cancer	4.71e-05	0.000299	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	4.71e-05	0.000299	CcSEcCtD
Emtricitabine—Cough—Capecitabine—breast cancer	4.7e-05	0.000298	CcSEcCtD
Emtricitabine—DCK—Metabolism—NCOA2—breast cancer	4.68e-05	0.0011	CbGpPWpGaD
Emtricitabine—Urinary tract infection—Epirubicin—breast cancer	4.67e-05	0.000296	CcSEcCtD
Emtricitabine—Neutropenia—Doxorubicin—breast cancer	4.66e-05	0.000296	CcSEcCtD
Emtricitabine—Hypersensitivity—Fluorouracil—breast cancer	4.64e-05	0.000294	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Doxorubicin—breast cancer	4.63e-05	0.000294	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Paclitaxel—breast cancer	4.63e-05	0.000294	CcSEcCtD
Emtricitabine—Fatigue—Paclitaxel—breast cancer	4.62e-05	0.000293	CcSEcCtD
Emtricitabine—Hepatitis—Methotrexate—breast cancer	4.61e-05	0.000292	CcSEcCtD
Emtricitabine—Asthenia—Gemcitabine—breast cancer	4.59e-05	0.000291	CcSEcCtD
Emtricitabine—Myalgia—Capecitabine—breast cancer	4.59e-05	0.000291	CcSEcCtD
Emtricitabine—Arthralgia—Capecitabine—breast cancer	4.59e-05	0.000291	CcSEcCtD
Emtricitabine—Pain—Paclitaxel—breast cancer	4.58e-05	0.000291	CcSEcCtD
Emtricitabine—Haematuria—Epirubicin—breast cancer	4.58e-05	0.000291	CcSEcCtD
Emtricitabine—Pharyngitis—Methotrexate—breast cancer	4.57e-05	0.00029	CcSEcCtD
Emtricitabine—Anxiety—Capecitabine—breast cancer	4.57e-05	0.00029	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	4.56e-05	0.000289	CcSEcCtD
Emtricitabine—Urinary tract disorder—Methotrexate—breast cancer	4.55e-05	0.000289	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Epirubicin—breast cancer	4.54e-05	0.000288	CcSEcCtD
Emtricitabine—DCK—Metabolism—FASN—breast cancer	4.54e-05	0.00107	CbGpPWpGaD
Emtricitabine—Pruritus—Gemcitabine—breast cancer	4.53e-05	0.000287	CcSEcCtD
Emtricitabine—DCK—Metabolism—BCHE—breast cancer	4.52e-05	0.00106	CbGpPWpGaD
Emtricitabine—Nausea—Thiotepa—breast cancer	4.52e-05	0.000287	CcSEcCtD
Emtricitabine—Urethral disorder—Methotrexate—breast cancer	4.52e-05	0.000287	CcSEcCtD
Emtricitabine—Infection—Docetaxel—breast cancer	4.51e-05	0.000286	CcSEcCtD
Emtricitabine—Weight decreased—Doxorubicin—breast cancer	4.51e-05	0.000286	CcSEcCtD
Emtricitabine—Sinusitis—Epirubicin—breast cancer	4.51e-05	0.000286	CcSEcCtD
Emtricitabine—Hyperglycaemia—Doxorubicin—breast cancer	4.5e-05	0.000285	CcSEcCtD
Emtricitabine—Diarrhoea—Mitoxantrone—breast cancer	4.5e-05	0.000285	CcSEcCtD
Emtricitabine—Diarrhoea—Irinotecan—breast cancer	4.5e-05	0.000285	CcSEcCtD
Emtricitabine—Pneumonia—Doxorubicin—breast cancer	4.47e-05	0.000284	CcSEcCtD
Emtricitabine—DCK—Metabolism—SLC5A5—breast cancer	4.47e-05	0.00105	CbGpPWpGaD
Emtricitabine—Nervous system disorder—Docetaxel—breast cancer	4.46e-05	0.000283	CcSEcCtD
Emtricitabine—Pruritus—Fluorouracil—breast cancer	4.45e-05	0.000283	CcSEcCtD
Emtricitabine—Thrombocytopenia—Docetaxel—breast cancer	4.45e-05	0.000282	CcSEcCtD
Emtricitabine—Infestation—Doxorubicin—breast cancer	4.45e-05	0.000282	CcSEcCtD
Emtricitabine—Infestation NOS—Doxorubicin—breast cancer	4.45e-05	0.000282	CcSEcCtD
Emtricitabine—Skin disorder—Docetaxel—breast cancer	4.41e-05	0.00028	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Paclitaxel—breast cancer	4.38e-05	0.000278	CcSEcCtD
Emtricitabine—Diarrhoea—Gemcitabine—breast cancer	4.38e-05	0.000278	CcSEcCtD
Emtricitabine—Renal failure—Doxorubicin—breast cancer	4.37e-05	0.000277	CcSEcCtD
Emtricitabine—Infection—Capecitabine—breast cancer	4.37e-05	0.000277	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Doxorubicin—breast cancer	4.36e-05	0.000276	CcSEcCtD
Emtricitabine—Dizziness—Irinotecan—breast cancer	4.35e-05	0.000276	CcSEcCtD
Emtricitabine—Rhinitis—Epirubicin—breast cancer	4.32e-05	0.000274	CcSEcCtD
Emtricitabine—Urinary tract infection—Doxorubicin—breast cancer	4.32e-05	0.000274	CcSEcCtD
Emtricitabine—Nervous system disorder—Capecitabine—breast cancer	4.31e-05	0.000274	CcSEcCtD
Emtricitabine—Hepatitis—Epirubicin—breast cancer	4.31e-05	0.000274	CcSEcCtD
Emtricitabine—DCK—Metabolism—NQO1—breast cancer	4.31e-05	0.00101	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—SLC2A1—breast cancer	4.31e-05	0.00101	CbGpPWpGaD
Emtricitabine—Diarrhoea—Fluorouracil—breast cancer	4.31e-05	0.000273	CcSEcCtD
Emtricitabine—Thrombocytopenia—Capecitabine—breast cancer	4.31e-05	0.000273	CcSEcCtD
Emtricitabine—Pharyngitis—Epirubicin—breast cancer	4.28e-05	0.000272	CcSEcCtD
Emtricitabine—Skin disorder—Capecitabine—breast cancer	4.27e-05	0.000271	CcSEcCtD
Emtricitabine—Urinary tract disorder—Epirubicin—breast cancer	4.26e-05	0.00027	CcSEcCtD
Emtricitabine—Urticaria—Paclitaxel—breast cancer	4.26e-05	0.00027	CcSEcCtD
Emtricitabine—Haematuria—Doxorubicin—breast cancer	4.24e-05	0.000269	CcSEcCtD
Emtricitabine—Connective tissue disorder—Epirubicin—breast cancer	4.24e-05	0.000269	CcSEcCtD
Emtricitabine—Body temperature increased—Paclitaxel—breast cancer	4.24e-05	0.000269	CcSEcCtD
Emtricitabine—Abdominal pain—Paclitaxel—breast cancer	4.24e-05	0.000269	CcSEcCtD
Emtricitabine—Urethral disorder—Epirubicin—breast cancer	4.23e-05	0.000268	CcSEcCtD
Emtricitabine—DCK—Metabolism—CYP3A4—breast cancer	4.21e-05	0.000988	CbGpPWpGaD
Emtricitabine—Hepatobiliary disease—Doxorubicin—breast cancer	4.2e-05	0.000267	CcSEcCtD
Emtricitabine—Vomiting—Mitoxantrone—breast cancer	4.18e-05	0.000265	CcSEcCtD
Emtricitabine—Vomiting—Irinotecan—breast cancer	4.18e-05	0.000265	CcSEcCtD
Emtricitabine—Sinusitis—Doxorubicin—breast cancer	4.17e-05	0.000265	CcSEcCtD
Emtricitabine—Immune system disorder—Methotrexate—breast cancer	4.16e-05	0.000264	CcSEcCtD
Emtricitabine—Dizziness—Fluorouracil—breast cancer	4.16e-05	0.000264	CcSEcCtD
Emtricitabine—Mediastinal disorder—Methotrexate—breast cancer	4.15e-05	0.000263	CcSEcCtD
Emtricitabine—Rash—Irinotecan—breast cancer	4.14e-05	0.000263	CcSEcCtD
Emtricitabine—Rash—Mitoxantrone—breast cancer	4.14e-05	0.000263	CcSEcCtD
Emtricitabine—Dermatitis—Irinotecan—breast cancer	4.14e-05	0.000263	CcSEcCtD
Emtricitabine—Dermatitis—Mitoxantrone—breast cancer	4.14e-05	0.000263	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Docetaxel—breast cancer	4.14e-05	0.000263	CcSEcCtD
Emtricitabine—DCK—Metabolism—CYP1B1—breast cancer	4.14e-05	0.000971	CbGpPWpGaD
Emtricitabine—Headache—Irinotecan—breast cancer	4.12e-05	0.000261	CcSEcCtD
Emtricitabine—Headache—Mitoxantrone—breast cancer	4.12e-05	0.000261	CcSEcCtD
Emtricitabine—Insomnia—Docetaxel—breast cancer	4.11e-05	0.000261	CcSEcCtD
Emtricitabine—Paraesthesia—Docetaxel—breast cancer	4.08e-05	0.000259	CcSEcCtD
Emtricitabine—Vomiting—Gemcitabine—breast cancer	4.07e-05	0.000258	CcSEcCtD
Emtricitabine—DCK—Metabolism—HSP90AA1—breast cancer	4.06e-05	0.000952	CbGpPWpGaD
Emtricitabine—Dyspnoea—Docetaxel—breast cancer	4.05e-05	0.000257	CcSEcCtD
Emtricitabine—Mental disorder—Methotrexate—breast cancer	4.04e-05	0.000256	CcSEcCtD
Emtricitabine—Rash—Gemcitabine—breast cancer	4.04e-05	0.000256	CcSEcCtD
Emtricitabine—Dermatitis—Gemcitabine—breast cancer	4.03e-05	0.000256	CcSEcCtD
Emtricitabine—Malnutrition—Methotrexate—breast cancer	4.01e-05	0.000255	CcSEcCtD
Emtricitabine—Headache—Gemcitabine—breast cancer	4.01e-05	0.000254	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Capecitabine—breast cancer	4.01e-05	0.000254	CcSEcCtD
Emtricitabine—Vomiting—Fluorouracil—breast cancer	4e-05	0.000254	CcSEcCtD
Emtricitabine—Rhinitis—Doxorubicin—breast cancer	4e-05	0.000254	CcSEcCtD
Emtricitabine—Dyspepsia—Docetaxel—breast cancer	4e-05	0.000254	CcSEcCtD
Emtricitabine—Hepatitis—Doxorubicin—breast cancer	3.99e-05	0.000253	CcSEcCtD
Emtricitabine—Insomnia—Capecitabine—breast cancer	3.98e-05	0.000252	CcSEcCtD
Emtricitabine—Rash—Fluorouracil—breast cancer	3.97e-05	0.000252	CcSEcCtD
Emtricitabine—Dermatitis—Fluorouracil—breast cancer	3.97e-05	0.000252	CcSEcCtD
Emtricitabine—Pharyngitis—Doxorubicin—breast cancer	3.96e-05	0.000251	CcSEcCtD
Emtricitabine—Paraesthesia—Capecitabine—breast cancer	3.95e-05	0.000251	CcSEcCtD
Emtricitabine—Hypersensitivity—Paclitaxel—breast cancer	3.95e-05	0.000251	CcSEcCtD
Emtricitabine—DCK—Metabolism—NCOA1—breast cancer	3.94e-05	0.000926	CbGpPWpGaD
Emtricitabine—Headache—Fluorouracil—breast cancer	3.94e-05	0.00025	CcSEcCtD
Emtricitabine—Urinary tract disorder—Doxorubicin—breast cancer	3.94e-05	0.00025	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Docetaxel—breast cancer	3.92e-05	0.000249	CcSEcCtD
Emtricitabine—Connective tissue disorder—Doxorubicin—breast cancer	3.92e-05	0.000249	CcSEcCtD
Emtricitabine—Dyspnoea—Capecitabine—breast cancer	3.92e-05	0.000249	CcSEcCtD
Emtricitabine—Fatigue—Docetaxel—breast cancer	3.92e-05	0.000248	CcSEcCtD
Emtricitabine—Urethral disorder—Doxorubicin—breast cancer	3.91e-05	0.000248	CcSEcCtD
Emtricitabine—Nausea—Irinotecan—breast cancer	3.9e-05	0.000248	CcSEcCtD
Emtricitabine—Nausea—Mitoxantrone—breast cancer	3.9e-05	0.000248	CcSEcCtD
Emtricitabine—Immune system disorder—Epirubicin—breast cancer	3.9e-05	0.000247	CcSEcCtD
Emtricitabine—DCK—Metabolism—STK11—breast cancer	3.89e-05	0.000913	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—CYP19A1—breast cancer	3.89e-05	0.000913	CbGpPWpGaD
Emtricitabine—Mediastinal disorder—Epirubicin—breast cancer	3.89e-05	0.000247	CcSEcCtD
Emtricitabine—Pain—Docetaxel—breast cancer	3.89e-05	0.000246	CcSEcCtD
Emtricitabine—Back pain—Methotrexate—breast cancer	3.88e-05	0.000246	CcSEcCtD
Emtricitabine—Dyspepsia—Capecitabine—breast cancer	3.87e-05	0.000246	CcSEcCtD
Emtricitabine—Asthenia—Paclitaxel—breast cancer	3.85e-05	0.000244	CcSEcCtD
Emtricitabine—Nausea—Gemcitabine—breast cancer	3.8e-05	0.000241	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Capecitabine—breast cancer	3.8e-05	0.000241	CcSEcCtD
Emtricitabine—Fatigue—Capecitabine—breast cancer	3.79e-05	0.000241	CcSEcCtD
Emtricitabine—Pruritus—Paclitaxel—breast cancer	3.79e-05	0.000241	CcSEcCtD
Emtricitabine—Mental disorder—Epirubicin—breast cancer	3.78e-05	0.00024	CcSEcCtD
Emtricitabine—Pain—Capecitabine—breast cancer	3.76e-05	0.000239	CcSEcCtD
Emtricitabine—Malnutrition—Epirubicin—breast cancer	3.75e-05	0.000238	CcSEcCtD
Emtricitabine—Nausea—Fluorouracil—breast cancer	3.74e-05	0.000237	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Docetaxel—breast cancer	3.72e-05	0.000236	CcSEcCtD
Emtricitabine—Anaemia—Methotrexate—breast cancer	3.71e-05	0.000235	CcSEcCtD
Emtricitabine—Diarrhoea—Paclitaxel—breast cancer	3.67e-05	0.000233	CcSEcCtD
Emtricitabine—Back pain—Epirubicin—breast cancer	3.63e-05	0.00023	CcSEcCtD
Emtricitabine—DCK—Metabolism—COMT—breast cancer	3.61e-05	0.000849	CbGpPWpGaD
Emtricitabine—Immune system disorder—Doxorubicin—breast cancer	3.6e-05	0.000229	CcSEcCtD
Emtricitabine—DCK—Metabolism—GSTP1—breast cancer	3.6e-05	0.000845	CbGpPWpGaD
Emtricitabine—Gastrointestinal pain—Capecitabine—breast cancer	3.6e-05	0.000228	CcSEcCtD
Emtricitabine—Mediastinal disorder—Doxorubicin—breast cancer	3.6e-05	0.000228	CcSEcCtD
Emtricitabine—Abdominal pain—Docetaxel—breast cancer	3.59e-05	0.000228	CcSEcCtD
Emtricitabine—Body temperature increased—Docetaxel—breast cancer	3.59e-05	0.000228	CcSEcCtD
Emtricitabine—DCK—Metabolism—HMOX1—breast cancer	3.55e-05	0.000833	CbGpPWpGaD
Emtricitabine—Dizziness—Paclitaxel—breast cancer	3.54e-05	0.000225	CcSEcCtD
Emtricitabine—DCK—Metabolism—ITPR1—breast cancer	3.54e-05	0.000831	CbGpPWpGaD
Emtricitabine—Cough—Methotrexate—breast cancer	3.5e-05	0.000222	CcSEcCtD
Emtricitabine—Mental disorder—Doxorubicin—breast cancer	3.5e-05	0.000222	CcSEcCtD
Emtricitabine—Urticaria—Capecitabine—breast cancer	3.49e-05	0.000222	CcSEcCtD
Emtricitabine—Body temperature increased—Capecitabine—breast cancer	3.48e-05	0.000221	CcSEcCtD
Emtricitabine—Abdominal pain—Capecitabine—breast cancer	3.48e-05	0.000221	CcSEcCtD
Emtricitabine—Malnutrition—Doxorubicin—breast cancer	3.47e-05	0.00022	CcSEcCtD
Emtricitabine—Anaemia—Epirubicin—breast cancer	3.47e-05	0.00022	CcSEcCtD
Emtricitabine—Myalgia—Methotrexate—breast cancer	3.42e-05	0.000217	CcSEcCtD
Emtricitabine—Arthralgia—Methotrexate—breast cancer	3.42e-05	0.000217	CcSEcCtD
Emtricitabine—Vomiting—Paclitaxel—breast cancer	3.41e-05	0.000216	CcSEcCtD
Emtricitabine—DCK—Metabolism—ABCB1—breast cancer	3.41e-05	0.0008	CbGpPWpGaD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.39e-05	0.000215	CcSEcCtD
Emtricitabine—Rash—Paclitaxel—breast cancer	3.38e-05	0.000214	CcSEcCtD
Emtricitabine—Dermatitis—Paclitaxel—breast cancer	3.38e-05	0.000214	CcSEcCtD
Emtricitabine—Back pain—Doxorubicin—breast cancer	3.36e-05	0.000213	CcSEcCtD
Emtricitabine—Headache—Paclitaxel—breast cancer	3.36e-05	0.000213	CcSEcCtD
Emtricitabine—Hypersensitivity—Docetaxel—breast cancer	3.35e-05	0.000212	CcSEcCtD
Emtricitabine—DCK—Metabolism—TYMS—breast cancer	3.34e-05	0.000785	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PLA2G4A—breast cancer	3.31e-05	0.000776	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—NCOR1—breast cancer	3.31e-05	0.000776	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—GSTM1—breast cancer	3.31e-05	0.000776	CbGpPWpGaD
Emtricitabine—Cough—Epirubicin—breast cancer	3.28e-05	0.000208	CcSEcCtD
Emtricitabine—Asthenia—Docetaxel—breast cancer	3.26e-05	0.000207	CcSEcCtD
Emtricitabine—Infection—Methotrexate—breast cancer	3.25e-05	0.000206	CcSEcCtD
Emtricitabine—Hypersensitivity—Capecitabine—breast cancer	3.24e-05	0.000206	CcSEcCtD
Emtricitabine—Pruritus—Docetaxel—breast cancer	3.21e-05	0.000204	CcSEcCtD
Emtricitabine—Nervous system disorder—Methotrexate—breast cancer	3.21e-05	0.000204	CcSEcCtD
Emtricitabine—Anaemia—Doxorubicin—breast cancer	3.21e-05	0.000204	CcSEcCtD
Emtricitabine—Thrombocytopenia—Methotrexate—breast cancer	3.21e-05	0.000203	CcSEcCtD
Emtricitabine—Arthralgia—Epirubicin—breast cancer	3.2e-05	0.000203	CcSEcCtD
Emtricitabine—Myalgia—Epirubicin—breast cancer	3.2e-05	0.000203	CcSEcCtD
Emtricitabine—Anxiety—Epirubicin—breast cancer	3.19e-05	0.000202	CcSEcCtD
Emtricitabine—Nausea—Paclitaxel—breast cancer	3.18e-05	0.000202	CcSEcCtD
Emtricitabine—Skin disorder—Methotrexate—breast cancer	3.18e-05	0.000202	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	3.17e-05	0.000201	CcSEcCtD
Emtricitabine—DCK—Metabolism—GPX1—breast cancer	3.17e-05	0.000743	CbGpPWpGaD
Emtricitabine—Asthenia—Capecitabine—breast cancer	3.16e-05	0.0002	CcSEcCtD
Emtricitabine—DCK—Metabolism—CYP1A1—breast cancer	3.13e-05	0.000736	CbGpPWpGaD
Emtricitabine—Pruritus—Capecitabine—breast cancer	3.11e-05	0.000197	CcSEcCtD
Emtricitabine—Diarrhoea—Docetaxel—breast cancer	3.11e-05	0.000197	CcSEcCtD
Emtricitabine—DCK—Metabolism—ERCC2—breast cancer	3.11e-05	0.00073	CbGpPWpGaD
Emtricitabine—Infection—Epirubicin—breast cancer	3.04e-05	0.000193	CcSEcCtD
Emtricitabine—Cough—Doxorubicin—breast cancer	3.03e-05	0.000192	CcSEcCtD
Emtricitabine—Diarrhoea—Capecitabine—breast cancer	3.01e-05	0.000191	CcSEcCtD
Emtricitabine—Nervous system disorder—Epirubicin—breast cancer	3.01e-05	0.000191	CcSEcCtD
Emtricitabine—Dizziness—Docetaxel—breast cancer	3e-05	0.000191	CcSEcCtD
Emtricitabine—Thrombocytopenia—Epirubicin—breast cancer	3e-05	0.00019	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Methotrexate—breast cancer	2.98e-05	0.000189	CcSEcCtD
Emtricitabine—Skin disorder—Epirubicin—breast cancer	2.98e-05	0.000189	CcSEcCtD
Emtricitabine—Insomnia—Methotrexate—breast cancer	2.96e-05	0.000188	CcSEcCtD
Emtricitabine—Arthralgia—Doxorubicin—breast cancer	2.96e-05	0.000188	CcSEcCtD
Emtricitabine—Myalgia—Doxorubicin—breast cancer	2.96e-05	0.000188	CcSEcCtD
Emtricitabine—Anxiety—Doxorubicin—breast cancer	2.95e-05	0.000187	CcSEcCtD
Emtricitabine—Paraesthesia—Methotrexate—breast cancer	2.94e-05	0.000187	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.94e-05	0.000186	CcSEcCtD
Emtricitabine—DCK—Metabolism—MTHFR—breast cancer	2.92e-05	0.000686	CbGpPWpGaD
Emtricitabine—Dyspnoea—Methotrexate—breast cancer	2.92e-05	0.000185	CcSEcCtD
Emtricitabine—Dizziness—Capecitabine—breast cancer	2.91e-05	0.000185	CcSEcCtD
Emtricitabine—Vomiting—Docetaxel—breast cancer	2.89e-05	0.000183	CcSEcCtD
Emtricitabine—Dyspepsia—Methotrexate—breast cancer	2.88e-05	0.000183	CcSEcCtD
Emtricitabine—Rash—Docetaxel—breast cancer	2.86e-05	0.000182	CcSEcCtD
Emtricitabine—Dermatitis—Docetaxel—breast cancer	2.86e-05	0.000182	CcSEcCtD
Emtricitabine—Headache—Docetaxel—breast cancer	2.85e-05	0.000181	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Methotrexate—breast cancer	2.83e-05	0.000179	CcSEcCtD
Emtricitabine—Fatigue—Methotrexate—breast cancer	2.82e-05	0.000179	CcSEcCtD
Emtricitabine—Infection—Doxorubicin—breast cancer	2.82e-05	0.000179	CcSEcCtD
Emtricitabine—Pain—Methotrexate—breast cancer	2.8e-05	0.000178	CcSEcCtD
Emtricitabine—Vomiting—Capecitabine—breast cancer	2.8e-05	0.000177	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Epirubicin—breast cancer	2.79e-05	0.000177	CcSEcCtD
Emtricitabine—Nervous system disorder—Doxorubicin—breast cancer	2.78e-05	0.000176	CcSEcCtD
Emtricitabine—Thrombocytopenia—Doxorubicin—breast cancer	2.78e-05	0.000176	CcSEcCtD
Emtricitabine—Rash—Capecitabine—breast cancer	2.77e-05	0.000176	CcSEcCtD
Emtricitabine—Insomnia—Epirubicin—breast cancer	2.77e-05	0.000176	CcSEcCtD
Emtricitabine—Dermatitis—Capecitabine—breast cancer	2.77e-05	0.000176	CcSEcCtD
Emtricitabine—Headache—Capecitabine—breast cancer	2.76e-05	0.000175	CcSEcCtD
Emtricitabine—Skin disorder—Doxorubicin—breast cancer	2.75e-05	0.000175	CcSEcCtD
Emtricitabine—Paraesthesia—Epirubicin—breast cancer	2.75e-05	0.000175	CcSEcCtD
Emtricitabine—Dyspnoea—Epirubicin—breast cancer	2.73e-05	0.000173	CcSEcCtD
Emtricitabine—Nausea—Docetaxel—breast cancer	2.7e-05	0.000171	CcSEcCtD
Emtricitabine—Dyspepsia—Epirubicin—breast cancer	2.7e-05	0.000171	CcSEcCtD
Emtricitabine—DCK—Metabolism—CAV1—breast cancer	2.69e-05	0.000633	CbGpPWpGaD
Emtricitabine—Gastrointestinal pain—Methotrexate—breast cancer	2.68e-05	0.00017	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Epirubicin—breast cancer	2.65e-05	0.000168	CcSEcCtD
Emtricitabine—Fatigue—Epirubicin—breast cancer	2.64e-05	0.000168	CcSEcCtD
Emtricitabine—Pain—Epirubicin—breast cancer	2.62e-05	0.000166	CcSEcCtD
Emtricitabine—Nausea—Capecitabine—breast cancer	2.61e-05	0.000166	CcSEcCtD
Emtricitabine—Urticaria—Methotrexate—breast cancer	2.6e-05	0.000165	CcSEcCtD
Emtricitabine—Abdominal pain—Methotrexate—breast cancer	2.59e-05	0.000164	CcSEcCtD
Emtricitabine—Body temperature increased—Methotrexate—breast cancer	2.59e-05	0.000164	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.58e-05	0.000164	CcSEcCtD
Emtricitabine—Insomnia—Doxorubicin—breast cancer	2.56e-05	0.000163	CcSEcCtD
Emtricitabine—Paraesthesia—Doxorubicin—breast cancer	2.55e-05	0.000162	CcSEcCtD
Emtricitabine—Dyspnoea—Doxorubicin—breast cancer	2.53e-05	0.00016	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Epirubicin—breast cancer	2.51e-05	0.000159	CcSEcCtD
Emtricitabine—Dyspepsia—Doxorubicin—breast cancer	2.5e-05	0.000158	CcSEcCtD
Emtricitabine—DCK—Metabolism—PIK3CG—breast cancer	2.45e-05	0.000576	CbGpPWpGaD
Emtricitabine—Gastrointestinal disorder—Doxorubicin—breast cancer	2.45e-05	0.000155	CcSEcCtD
Emtricitabine—Fatigue—Doxorubicin—breast cancer	2.44e-05	0.000155	CcSEcCtD
Emtricitabine—Urticaria—Epirubicin—breast cancer	2.43e-05	0.000154	CcSEcCtD
Emtricitabine—Pain—Doxorubicin—breast cancer	2.42e-05	0.000154	CcSEcCtD
Emtricitabine—Abdominal pain—Epirubicin—breast cancer	2.42e-05	0.000154	CcSEcCtD
Emtricitabine—Body temperature increased—Epirubicin—breast cancer	2.42e-05	0.000154	CcSEcCtD
Emtricitabine—Hypersensitivity—Methotrexate—breast cancer	2.41e-05	0.000153	CcSEcCtD
Emtricitabine—Asthenia—Methotrexate—breast cancer	2.35e-05	0.000149	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Doxorubicin—breast cancer	2.32e-05	0.000147	CcSEcCtD
Emtricitabine—Pruritus—Methotrexate—breast cancer	2.32e-05	0.000147	CcSEcCtD
Emtricitabine—Hypersensitivity—Epirubicin—breast cancer	2.26e-05	0.000143	CcSEcCtD
Emtricitabine—Urticaria—Doxorubicin—breast cancer	2.25e-05	0.000143	CcSEcCtD
Emtricitabine—Abdominal pain—Doxorubicin—breast cancer	2.24e-05	0.000142	CcSEcCtD
Emtricitabine—Body temperature increased—Doxorubicin—breast cancer	2.24e-05	0.000142	CcSEcCtD
Emtricitabine—Diarrhoea—Methotrexate—breast cancer	2.24e-05	0.000142	CcSEcCtD
Emtricitabine—Asthenia—Epirubicin—breast cancer	2.2e-05	0.000139	CcSEcCtD
Emtricitabine—Pruritus—Epirubicin—breast cancer	2.17e-05	0.000138	CcSEcCtD
Emtricitabine—Dizziness—Methotrexate—breast cancer	2.17e-05	0.000137	CcSEcCtD
Emtricitabine—DCK—Metabolism—PIK3CD—breast cancer	2.16e-05	0.000507	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—ALB—breast cancer	2.13e-05	0.0005	CbGpPWpGaD
Emtricitabine—Diarrhoea—Epirubicin—breast cancer	2.1e-05	0.000133	CcSEcCtD
Emtricitabine—Hypersensitivity—Doxorubicin—breast cancer	2.09e-05	0.000133	CcSEcCtD
Emtricitabine—Vomiting—Methotrexate—breast cancer	2.08e-05	0.000132	CcSEcCtD
Emtricitabine—Rash—Methotrexate—breast cancer	2.06e-05	0.000131	CcSEcCtD
Emtricitabine—Dermatitis—Methotrexate—breast cancer	2.06e-05	0.000131	CcSEcCtD
Emtricitabine—Headache—Methotrexate—breast cancer	2.05e-05	0.00013	CcSEcCtD
Emtricitabine—DCK—Metabolism—NOS3—breast cancer	2.04e-05	0.000478	CbGpPWpGaD
Emtricitabine—Asthenia—Doxorubicin—breast cancer	2.03e-05	0.000129	CcSEcCtD
Emtricitabine—Dizziness—Epirubicin—breast cancer	2.03e-05	0.000129	CcSEcCtD
Emtricitabine—Pruritus—Doxorubicin—breast cancer	2.01e-05	0.000127	CcSEcCtD
Emtricitabine—Vomiting—Epirubicin—breast cancer	1.95e-05	0.000124	CcSEcCtD
Emtricitabine—Nausea—Methotrexate—breast cancer	1.95e-05	0.000123	CcSEcCtD
Emtricitabine—Diarrhoea—Doxorubicin—breast cancer	1.94e-05	0.000123	CcSEcCtD
Emtricitabine—Rash—Epirubicin—breast cancer	1.93e-05	0.000123	CcSEcCtD
Emtricitabine—Dermatitis—Epirubicin—breast cancer	1.93e-05	0.000122	CcSEcCtD
Emtricitabine—Headache—Epirubicin—breast cancer	1.92e-05	0.000122	CcSEcCtD
Emtricitabine—DCK—Metabolism—PIK3CB—breast cancer	1.88e-05	0.000442	CbGpPWpGaD
Emtricitabine—Dizziness—Doxorubicin—breast cancer	1.88e-05	0.000119	CcSEcCtD
Emtricitabine—DCK—Metabolism—PTGS2—breast cancer	1.86e-05	0.000438	CbGpPWpGaD
Emtricitabine—Nausea—Epirubicin—breast cancer	1.82e-05	0.000115	CcSEcCtD
Emtricitabine—Vomiting—Doxorubicin—breast cancer	1.8e-05	0.000114	CcSEcCtD
Emtricitabine—Rash—Doxorubicin—breast cancer	1.79e-05	0.000113	CcSEcCtD
Emtricitabine—Dermatitis—Doxorubicin—breast cancer	1.79e-05	0.000113	CcSEcCtD
Emtricitabine—Headache—Doxorubicin—breast cancer	1.78e-05	0.000113	CcSEcCtD
Emtricitabine—Nausea—Doxorubicin—breast cancer	1.68e-05	0.000107	CcSEcCtD
Emtricitabine—DCK—Metabolism—PTEN—breast cancer	1.63e-05	0.000382	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—PIK3CA—breast cancer	1.15e-05	0.000269	CbGpPWpGaD
Emtricitabine—DCK—Metabolism—AKT1—breast cancer	9.37e-06	0.00022	CbGpPWpGaD
